UnitedHealth Group Incorporated $UNH Stock: Mesirow Financial Investment Management Inc. Raises Stake

Mesirow Financial Investment Management Inc. lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 76,029 shares of the healthcare conglomerate’s stock after acquiring an additional 3,525 shares during the period. Mesirow Financial Investment Management Inc.’s holdings in UnitedHealth Group were worth $27,910,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in UNH. Montaka Global Pty Ltd acquired a new stake in UnitedHealth Group during the third quarter worth about $5,506,000. Keybank National Association OH boosted its stake in UnitedHealth Group by 7.2% in the third quarter. Keybank National Association OH now owns 197,486 shares of the healthcare conglomerate’s stock valued at $72,493,000 after acquiring an additional 13,241 shares during the period. Csenge Advisory Group boosted its stake in UnitedHealth Group by 17.7% in the third quarter. Csenge Advisory Group now owns 7,412 shares of the healthcare conglomerate’s stock valued at $2,721,000 after acquiring an additional 1,115 shares during the period. Cassia Capital Partners LLC grew its holdings in shares of UnitedHealth Group by 3.3% during the third quarter. Cassia Capital Partners LLC now owns 3,551 shares of the healthcare conglomerate’s stock valued at $1,304,000 after purchasing an additional 114 shares during the last quarter. Finally, D Orazio & Associates Inc. raised its position in shares of UnitedHealth Group by 0.4% during the 3rd quarter. D Orazio & Associates Inc. now owns 49,062 shares of the healthcare conglomerate’s stock worth $18,010,000 after purchasing an additional 178 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth’s profits are reportedly improving despite fewer members and lower Optum Health sales, with higher margins and pricing discipline supporting the recovery. Medical-cost pressures remain a risk. Article: Leaner and Meaner: Are UNH’s Profits Getting Bigger?
• Neutral Sentiment: Madeline Bell, former CEO of Children’s Hospital of Philadelphia, joined UnitedHealth’s board. Her healthcare leadership adds experience, though the appointment alone may have limited near-term earnings impact. Article: Madeline Bell Joins UnitedHealth Group Board of Directors
• Neutral Sentiment: A proposed bill would give some ACA marketplace customers a special enrollment period if their provider leaves a plan’s network. It is not enacted, and the potential effect on UNH is uncertain. Article: Right to Re-Enroll Act of 2026
• Negative Sentiment: UnitedHealth plans to drop Medicare coverage in 140 counties and leave Wyoming. The pullback could reduce membership and revenue in affected markets, although exiting areas with unfavorable economics may help control costs. Article: UnitedHealth Group Will Drop Medicare Plans In 140 Counties And Leave Wyoming

UnitedHealth Group Stock Performance

UNH opened at $404.88 on Wednesday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. The business’s 50 day moving average is $390.98 and its 200-day moving average is $364.53. The stock has a market cap of $362.78 billion, a PE ratio of 23.12, a price-to-earnings-growth ratio of 1.44 and a beta of 0.51. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same period in the prior year, the company posted $2.59 EPS. The business’s revenue for the quarter was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be issued a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on UNH. Piper Sandler raised their price target on UnitedHealth Group from $502.00 to $504.00 and gave the stock an “overweight” rating in a report on Wednesday, October 14th. BMO Capital Markets set a $512.00 price objective on UnitedHealth Group in a research note on Tuesday, July 21st. Stephens set a $500.00 target price on UnitedHealth Group in a research report on Friday, October 16th. Royal Bank Of Canada boosted their price target on shares of UnitedHealth Group from $478.00 to $498.00 and gave the company an “outperform” rating in a report on Tuesday, October 20th. Finally, The Goldman Sachs Group upped their price target on shares of UnitedHealth Group from $435.00 to $490.00 and gave the stock a “buy” rating in a research report on Friday, July 17th. Twenty research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $463.93.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.19% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.